Cosnes J, Gower-Rousseau C, Seksik P, Cortot A: Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140:1785-1794.
Irvine EJ: Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis 2008, 14:554-565.
Travis SP, Stange EF, Lemann M, Oresland T, Bemelman WA, Chowers Y, Colombel JF, D'Haens G, Ghosh S, Marteau P, Kruis W, Mortensen NJ, Penninckx F, Gassull M: European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis 2008, 2:24-62.
Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG, LeMair AW, Malfertheiner, Ouyang Q, Rey JF, Sood A, Steinwurz F, Thomsen OO, Thomson A, Watermeyer G: World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010, 16:112-124.
Kornbluth A, Sachar DB: Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010, 105:501-523.
Loftus EV Jr: A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies. Inflamm Bowel Dis 2006, 12:1107-1113.
Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J: Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis 2009, 15:581-588.
Legal and Ethical Guidelines for Healthcare Market Research. [http://www.bhbia.org.uk/Guidelines/LegalandEthicalGuidelines/tabid/143/Default.aspx].
Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J: The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci 2010, 55:1044-1052.
Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
Kane S, Huo D, Aikens J, Hanauer S: Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003, 114:39-43.
Bhatt J, Patil S, Joshi A, Abraham P, Desai D: Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian J Gastroenterol 2009, 28:143-146.
Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV: Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther 2009, 29:247-257.
Kane SV: Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:577-585.
Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A: Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 2010, 10:134.
van Hees PAM, van Tongeren JHM: Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982, 4:333-336.
Kane SV, Cohen RD, Aikens JE, Hanauer SB: Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001, 96:2929-2933.
Shale MJ, Riley SA: Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003, 18:191-198.
Ediger JP, Walker JR, Graff L, Lix L, Clara I, Rawsthorne P, Rogala L, Miller N, McPhail C, Deering K, Bernstein CN: Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007, 102:1417-1426.
Moshkovska T, Stone MA, Clatworthy J, Smith RM, Bankart J, Baker R, Wang J, Horne R, Mayberry JF: An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Aliment Pharmacol Ther 2009, 30:1118-1127.
Kane S, Shaya F: Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci 2008, 53:1020-1024.
Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn M, Moum B: Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004, 39:365-373.
Casellas F, Arenas JI, Baudet JS, Fabregas S, Garcia N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L, Malagelada JR: Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11:488-496.
Janke KH, Klump B, Gregor M, Meisner C, Haeuser W: Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:272-286.
Arbuthnott A, Sharpe D: The effect of physician-patient collaboration on patient adherence in non-psychiatric medicine. Patient Educ Couns 2009, 77:60-67.
Zolnierek KB, Dimatteo MR: Physician communication and patient adherence to treatment: a meta-analysis. Med Care 2009, 47:826-834.
Schreiber S, Panes J, Louis E, Holley D, Buch M, Pym N, Paridaens K: National differences in ulcerative colitis experience and management among patients from five European countries: an online survey. doi:10.1016/j.crohns.2012.07.027
Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR: Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000, 46:336-343.
Magro F, Portela F, Lago P, Deus J, Cotter J, Cremers I, Vieira A, Peixe P, Caldeira P, Lopes H, Goncalves R, Reis J, Cravo M, Barros L, Ministro P, Lurdes TM, Duarte A, Campos M, Carvalho L: Inflammatory bowel disease: a patient's and caregiver's perspective. Dig Dis Sci 2009, 54:2671-2679.
Bolge SC, Waters H, Piech CT: Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey. Clin Ther 2010, 32:238-245.